Taking low dose Aspirin can reduce Ovarian Cancer risk


Researchers have found that anti-inflammatory medicines can play a major role in helping women deal with the risk of ovarian cancer. The researchers at the TH Chan School of Public Health of the Harvard University did the work. They discovered that by taking low dose Aspirin it was possible to bring down the risk of ovarian cancer. You need to take such Aspirin on a regular basis though. They found it that the reduction rate is 23 percent. Yet, if you use certain drugs for a long period of time it could actually increase the risk of ovarian cancer in your body. Examples of such drugs would be ibuprofen, non-steroidal anti-inflammatory drugs, and naproxen. You get ibuprofen in Advil and naproxen in Aleve.

The word low dose aspirin signifies pills that are of 100 mg or lower than that.

Where was the study published?

The study came out in print in a publication named JAMA Oncology on 4th October 2018. For the purpose of the study, the researchers looked at data of more than 20,000 women in the USA. These women took part in the two programmes Nurses’ Health Study and Nurses’ Health Study II. Among the women studied 1054 had developed ovarian cancer. Researchers then took a look at the kind of medicines they were consuming regularly. The researchers found that women who were taking at least 10 doses of NSAIDs a week for many years were more at risk against ovarian cancer.

In cases of women who were consuming the medicines to a limited extent on a regular basis the researchers found that the risk levels were a lot lower. However, the same is not applicable to women who were consuming the standard dose of aspirin on a regular basis, for a really long period of time.


The role of future research in this regard

It is expected that in the days ahead this research would shed further light in this regard. It would reveal if certain women are actually being helped by consuming aspirin at low doses. This is in the context of ovarian cancer.

How was this study different from the ones done before in this regard?

In case of this study, the researchers were able to analyze low dose aspirin in a separate way from standard dose versions of the same medicine.  This made this particular study different from its predecessors. The research was led by Mollie Barnard, a doctoral student at the Harvard Chan School. Apart from that, she is also a postdoctoral fellow at the Huntsman Cancer Institute of the University of Utah.

She said quite clearly that the research of her team makes it pretty clear that when it comes to research on cancer risk and aspirin usage it is very important to take into account the dosage of the medicine in question. According to her, these results also shed light on how important it is for doctors and patients to communicate with each other about the benefits and risks of consuming low dose aspirin with regards to ovarian cancer.


As far as women in the USA are concerned ovarian cancer happens to be the fifth highest reason for deaths related to the disease. This is why it is expected that this particular research and its findings would be of immense help!

Leave a Reply

Your email address will not be published. Required fields are marked *